retatrutide type 1 diabetes Lilly Prepares for FDA Filing Following Additional Phase 3 Data in Diabetes, CVD The Science Behind Retatrutide: A

Disorders of fatty acid oxidation and organic acidemias can lead to secondary carnitine deficiency by trapping free carnitine by conjugating it with acyl moieties which accumulate in these conditions

Discussion This machine learning analysis demonstrates that the use of SGLT2is and GLP-1RAs in real-world Italian diabetes care is influenced not only by cardiorenal risk profiles but also by demographic and anthropometric variables such as age, sex, and BMI

So simple stuff, right

Kolterman OG, Kim DD, Shen L, Ruggles JA, Nielsen LL, Fineman MS, Baron AD

I think that once Mounjaro is approved for weight loss at the end of 2023 this trend will gain steam in a significant way, which would likely reflect in Q2-Q3 2024 earnings for PHG, RMD etc